Octopus Biosafety (STU:OCR) Sloan Ratio %: 0.00% (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:OCR Octopus Biosafety STU:OCR
7 GF Score
Price €0.15
GF Value €0.08
! 2 Warning Signs
View Full Analysis

What is Octopus Biosafety Sloan Ratio %?

Octopus Biosafety STU:OCR 7 Sloan Ratio % is 0.00% as of Dec. 2024. GuruFocus rates STU:OCR with a GF Score™ of 7/100 and a GF Value™ of €0.08. The stock has 2 warning signs investors should review.

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Octopus Biosafety's Sloan Ratio for the quarter that ended in Dec. 2024 was 0.00%.

As of Dec. 2024, Octopus Biosafety has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Octopus Biosafety  (STU:OCR) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2024, Octopus Biosafety has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Octopus Biosafety Sloan Ratio % Related Terms


Octopus Biosafety Sloan Ratio % Historical Data

* Premium members only.

The historical data trend for Octopus Biosafety's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Octopus Biosafety Sloan Ratio % Chart

Octopus Biosafety Annual Data
Trend Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Octopus Biosafety Semi-Annual Data
Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:OCR vs DELL, ANET, SNDK: Sloan Ratio % Comparison

For the Computer Hardware subindustry, Octopus Biosafety's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Octopus Biosafety Sloan Ratio % vs Hardware Industry

For the Hardware industry and Technology sector, Octopus Biosafety's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Octopus Biosafety's Sloan Ratio % falls into.


STU:OCR
7GF Score
Octopus Biosafety STU:OCR
Sloan Ratio % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Octopus Biosafety Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Octopus Biosafety's Sloan Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2024 )-Cash Flow from Operations (A: Dec. 2024 )
-Cash Flow from Investing (A: Dec. 2024 ))/Total Assets (A: Dec. 2024 )
=(-0.659-0
-0)/0.489
=-134.76%

Octopus Biosafety's Sloan Ratio for the quarter that ended in Dec. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2024 )
=(-0.659-0
-0)/0.489
=-134.76%

For company reported annually, GuruFocus uses latest annual data as the TTM data. Octopus Biosafety's Net Income for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.66 Mil.
Octopus Biosafety's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.
Octopus Biosafety's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Sloan Ratio % →
What does a Sloan Ratio % of 0.00% mean?
Octopus Biosafety (STU:OCR) has a Sloan Ratio % of 0.00% as of Dec. 2024. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Octopus Biosafety and its competitors.
Is Octopus Biosafety's Sloan Ratio % too high?
Octopus Biosafety's current Sloan Ratio % is 0.00%. Overall, Octopus Biosafety has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's Sloan Ratio % compare to DELL and ANET?
Octopus Biosafety's Sloan Ratio % of 0.00% can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Hardware company?
A good Sloan Ratio % depends on the Hardware industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Octopus Biosafety and its competitors. Octopus Biosafety's current Sloan Ratio % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (STU:OCR) has a current Sloan Ratio % of 0.00%. The stock's GF Value™ is €0.08, compared to a current price of €0.15 — trading 83.8% above its estimated fair value. The current Sloan Ratio % is 0.00%. Octopus Biosafety's overall GF Score™ is 7/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Octopus Biosafety (STU:OCR), the current Sloan Ratio % is 0.00% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Octopus Biosafety (STU:OCR) Overvalued in 2026?

Based on GuruFocus' analysis, Octopus Biosafety stock appears to be overvalued. The current stock price of €0.15 is trading 83.8% above its estimated GF Value™ of €0.08.

Key valuation signals for STU:OCR:

  • Sloan Ratio %: 0.00%
  • GF Value™: €0.08 vs. price of €0.15 (83.8% above fair value)
  • GF Score™: 7/100 with 2 warning signs

No single metric tells the full story. See the STU:OCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Octopus Biosafety Business Description

Other Exchanges MLOCT:France
Address 29 rue Saint Pierre, Cholet, FRA, 49300
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
7GF Score

Get the complete analysis for STU:OCR

Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.15
Price
€0.08
GF Value